NCT03351803

BRCA Founder OutReach (BFOR) Study

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 5,412 (actual)
• Sponsor: Memorial Sloan Kettering Cancer Center · Academic / Other
• Sex: All
• Age: 25 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to learn how to provide BRCA gene testing to a larger number of people as well as to make testing part of a person's regular medical care.

Conditions

• BRCA1 Mutation
• BRCA2 Mutation

Interventions

Type	Name	Description
OTHER	BFOR Digital Health solution/Web Portal	A digital health solution with Internet-based participant recruitment and ascertainment is a mechanism for distributing access to genetic testing to populations who might not otherwise have access. For this project, LifeLink will build a private web-portal designed by the PI's of the study as described in this protocol, including the wireframes that are in the appendices, that will enable secure contact between study participants and the participating commercial laboratory (Quest Diagnostics) and BFOR researchers, as well as facilitate contacts between study participants and their primary care providers and/or a list of BFOR study centers and BFOR providers.

Timeline

• Start date: 2017-11-10
• Primary completion: 2026-05-10
• Completion: 2026-05-10
• First posted: 2017-11-24
• Last updated: 2026-03-06

Locations

5 sites across 1 country: United States